Join us March 28-31 at the BIO-Europe Spring 2022 conference. We are excited to connect with industry experts to discuss our rapid iPSC differentiation technology and its application in disease modeling.
Register for the digital conference experience.
Learn more about iPSC differentiation products and services.
Join our upcoming webinar and hear from our expert panelists Norihiro Yumoto, Ph.D. and Stephanie C. Napier from Jiksak Bioengineering and Michaela Kilander, Ph.D, from Elixirgen Scientific for innovative tools. Register now for free!
Watch webinar and hear from our expert panelists Kara L. Gordon, Ph.D. from the Vala Sciences, Inc. and Michal Millrod, Ph.D, from Elixirgen Scientific as they discuss modeling neurotoxicity and neurological disease using functional iPSC-derived neurons.
Speaker bio
Dr. Kara L. Gordon
Director, Neurobiology, Vala Sciences, Inc.
Dr. Kara L. Gordon is the Director of Neurobiology at Vala Sciences, a biotech located in San Diego, CA. Vala uses its flagship kinetic image cytometer (IC-20O-KIC®) with high throughput automation and analytics with iPSC-derived cells to measure single-cell responses to drugs and in disease conditions. Dr. Gordon is leading efforts to create iPSC-derived neuron and neuron-astrocyte-microglia co-cultures. These culture systems can be used to model neurological disorders for drug discovery and for neurotoxicity screening. She received her Ph.D. in Neuroscience at the University of Iowa and completed post-doctoral training at the University of California San Diego before joining the team at Vala Sciences 4 years ago.
Michal Millrod
Scientist II, Elixirgen Scientific, Inc.
Dr. Michal Millrod joined Elixirgen Scientific in the beginning of 2020. She has a Ph.D. in Immunology from the Department of Molecular Biology and Genomics at the Johns Hopkins University School of Medicine. Dr. Millrod’s graduate research was conducted in the Johns Hopkins Institute for Cell Engineering and she completed a postdoctoral fellowship in vascular biology at the Johns Hopkins University School of Medicine. Dr. Millrod has over a decade of experience culturing and differentiating human pluripotent stem cells. She has particular expertise in differentiation towards mesodermal lineages such as hematopoietic, cardiac, and endothelial cells. At Elixirgen Scientific Dr. Millrod specializes in creating consistent, intuitive, and easy-to-follow User Guides to ultimately save clients’ time and increase their efficiency so they can focus on achieving their research goals.
Watch our webinar and hear from our expert panelists Mohamed Hassan Farah, Ph.D. from the Johns Hopkins University School of Medicine and Muzammil Ahmad, Ph.D, from Elixirgen Scientific as they discuss human iPSC-derived neuromuscular research and transcription factor based fast hiPSC differentiation.
Speaker bios
Mohamed Hassan Farah, Ph.D.
Associate Professor of Neurology, The Johns Hopkins University School of Medicine
Dr. Mohamed H. Farah is an associate professor in the department of neurology as well as the department of neuroscience at The Johns Hopkins University School of Medicine. Dr. Farah received his undergraduate degree in biochemistry from Virginia Tech in Blacksburg, Virginia. He earned his Ph.D. in neuroscience from the University of Michigan in Ann Arbor, Michigan and completed a postdoctoral fellowship in the department of pathology at The Johns Hopkins University School of Medicine. The Mohamed Farah Lab studies axonal regeneration in the peripheral nervous system. His team is currently engaged in interactions of target tissues and human axon from IPSC-derived neurons.
Muzammil Ahmad, Ph.D.
Scientist III, Elixirgen Scientific Inc.
Dr. Muzammil Ahmad joined Elixirgen Scientific in 2016. He has a Ph.D. in Biotechnology from the National Centre for Cell Science (NCSS) in India, and completed a postdoctoral fellowship at the NIH National Institute on Aging. He has over 15 years experience in the biotech and pharmaceutical research industries. Dr. Ahmad works in Research & Development at Elixirgen Scientific, where he supervises a team of Ph.D. scientists and lab assistants that develop and fine-tune commercial iPSC-derived differentiation kits for a myriad of cell types. Dr. Ahmad specializes in creating intuitive and easy-to-follow protocols to ultimately save clients’ time and increase their efficiency so they can focus on achieving their research goals.
Join us June 10-11 & 14-18 as we meet with leaders in the biotech and pharmaceutical industries at the BioDigital virtual conference. We're available now for one-on-one partnering!
Join us May 18-19 as we meet with life sciences professionals from the Northeast and beyond at the BioNJ 2021 BioPartnering digital conference!
Join us at @alliancerm’s 2021 Cell & Gene Meeting on the Med April 6-9! Excited to explore how our innovative iPSC differentiation technologies can advance the cutting-edge regenerative medicine and advanced therapy sectors.
Looking forward to meeting with leaders in biotech and pharma at the upcoming Bio-Europe Spring Digital March 22-25. Excited to share how our innovative human iPSC differentiation technology and services can contribute to their research goals.
Continuing to build strong relationships with leading pharmaceutical and biotech companies while exploring how Elixirgen Scientific’s human iPSC differentiation technologies accelerate and drive research in their areas of study. Join us February 23-25! #biocomglobalpartnering
